Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Allena Pharmaceuticals Inc. (ALNA)

1.61   0.13 (8.78%) 10-01 16:07
Open: 1.4 Pre. Close: 1.48
High: 1.75 Low: 1.3612
Volume: 3,477,275 Market Cap: 62M
Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company, which engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. The company is headquartered in Newton, Massachusetts and currently employs 45 full-time employees. The firm is focused on developing and commercializing non-systemic oral protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. Its lead product candidate, ALLN-177, is in an ongoing Phase II clinical trial and is being developed for the chronic management of hyperoxaluria and kidney stones. ALLN-177 is an orally administered, recombinant oxalate-degrading enzyme. ALLN-177 targets oxalate in the gastrointestinal (GI) tract to reduce the burden of both dietary and endogenously produced oxalate. ALLN-177 has the potential to decrease the oxalate available systemically for deposition as calcium oxalate crystals or stones in the kidneys, as well as to reduce the incidence of calcium oxalate related complications. Its technological approach enables the design and development of oral protein therapies that remain in the GI tract.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.783 - 1.793 1.793 - 1.802
Low: 1.31 - 1.32 1.32 - 1.329
Close: 1.464 - 1.48 1.48 - 1.495

Technical analysis

as of: 2020-10-01 3:30:19 PM
Overall:       
Stoxline posted a STRONG BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.08     One year: 2.43
Support: Support1: 1.34    Support2: 1.07
Resistance: Resistance1: 1.78    Resistance2: 2.08
Pivot: 1.31
Moving Average: MA(5): 1.37     MA(20): 1.28
MA(100): 1.57     MA(250): 2.07
MACD: MACD(12,26): 0.02     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 58.79     %D(3): 42.68
RSI: RSI(14): 70.49
52-week: High: 6.30  Low: 0.52  Change(%): -57.0
Average Vol(K): 3-Month: 193027  10-Days: 373850

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ALNA has closed above the upper band by 20.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 2.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 01 Oct 2020
Allena Pharmaceuticals Inc. (ALNA) average volume reaches $1.33M: Are the Stars Lining Up for Investors? - News Daemon

Wed, 30 Sep 2020
Boiling and ready to burst as Allena Pharmaceuticals Inc. (ALNA) last month performance was -11.68% - The InvestChronicle

Wed, 30 Sep 2020
Allena Pharmaceuticals Inc. (ALNA) upgraded Issued by Wall Street Gurus - The News Heater

Wed, 30 Sep 2020
Allena Pharmaceuticals Announces $25 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures - GlobeNewswire

Tue, 29 Sep 2020
Allena Pharmaceuticals, Inc. (ALNA) Seems To Be Turning Some Investors Off - Invest Million

Tue, 22 Sep 2020
Allena Pharmaceuticals Inc. (NASDAQ:ALNA) Commence Dosing In Phase 1 ALLN-346 Clinical Trial - BP Journal

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38
Shares Float (M) 28
% Held by Insiders 10.15
% Held by Institutions 61.65
Shares Short (K) 1,430
Shares Short P. Month (K) 1,150

Stock Financials

EPS -1.590
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.570
Profit Margin
Operating Margin
Return on Assets (ttm) -57.6
Return on Equity (ttm) -139.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -36
Levered Free Cash Flow (M) -21

Stock Valuations

PE Ratio -1.08
PEG Ratio
Price to Book value 3.02
Price to Sales
Price to Cash Flow -1.80

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.